Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.31 +0.12 (+0.59%)
At close: Oct 22, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Acadia Pharmaceuticals (ACAD) reported Return on Capital Employed [ROCE] of 6.58% for Q2 2026, down 21.32 percentage points from 27.90% a year earlier but up 0.25 percentage points from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Acadia Pharmaceuticals posted Return on Capital Employed [ROCE] of 9.54%, down 30.71 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of +51.87 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at 40.24% in FY2024 (+57.96 pp), -17.72% in FY2023 (+25.42 pp), -43.14% in FY2022 (-16.72 pp) and -26.41% in FY2021 (+15.92 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -47.62% in Q4 2022 and a high of 33.57% in Q4 2024.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last three quarters, with an average year-over-year change of +12.21 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2024 (a gain of 54.73 percentage points); the low point was Q4 2025 (a drop of 24.62 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 6.32% (Q1 2026), 8.96% (Q4 2025) and 26.14% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 17.52%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 17.92%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.28%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 19.32%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 16.76%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 16.66%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -5.97%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 11.86%
10 Acadia Pharmaceuticals 3.50 Bn 21.37 Mn 279.64 Mn 6.58%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.58%
Mar 31, 2026 6.32%
Dec 31, 2025 8.96%
Sep 30, 2025 26.14%
Jun 30, 2025 27.90%
Mar 31, 2025 27.39%
Dec 31, 2024 33.57%
Sep 30, 2024 18.66%
Jun 30, 2024 4.17%
Mar 31, 2024 -0.97%
Dec 31, 2023 -16.81%
Sep 30, 2023 -36.07%
Jun 30, 2023 -27.65%
Mar 31, 2023 -41.32%
Dec 31, 2022 -47.62%
Sep 30, 2022 -45.25%
Jun 30, 2022 -41.26%
Mar 31, 2022 -39.94%
Dec 31, 2021 -27.81%
Sep 30, 2021 -30.49%
API Access

Acadia Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ACAD&period=max&api_key=YOUR_API_KEY